Steven Valiquette
Stock Analyst at Mizuho Securities
(1.09)
# 3,647
Out of 4,455 analysts
706
Total ratings
51%
Success rate
-0.6%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintained: Buy | $295 → $270 | $171.36 | +57.56% | 10 | Jun 3, 2026 | |
| DOCS Doximity | Maintained: Hold | $34 → $26 | $20.88 | +24.52% | 8 | May 14, 2026 | |
| XRAY DENTSPLY SIRONA | Maintained: Hold | $16 → $14 | $11.01 | +27.16% | 31 | May 6, 2026 | |
| HSIC Henry Schein | Maintained: Hold | $88 → $82 | $84.95 | -3.47% | 23 | May 6, 2026 | |
| ALGN Align Technology | Maintained: Buy | $215 → $220 | $178.43 | +23.30% | 34 | Apr 30, 2026 | |
| PHR Phreesia | Maintained: Buy | $22 → $19 | $10.07 | +88.68% | 4 | Mar 24, 2026 | |
| LFMD LifeMD | Upgraded: Buy | $6 → $8 | $4.13 | +93.70% | 8 | Mar 16, 2026 | |
| GDRX GoodRx Holdings | Maintained: Hold | $4 → $3 | $2.80 | +7.14% | 7 | Feb 27, 2026 | |
| TDOC Teladoc Health | Maintained: Hold | $10 → $6 | $8.39 | -28.49% | 23 | Feb 26, 2026 | |
| MDLN Medline | Maintained: Buy | $48 → $53 | $38.87 | +36.35% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $6 | $5.22 | +14.94% | 5 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $235 | $237.92 | -1.23% | 33 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $885 | $763.51 | +15.91% | 45 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $27 | $26.96 | +0.15% | 9 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $42 | $19.90 | +111.06% | 6 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $85 → $100 | $79.53 | +25.74% | 5 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 → $380 | $286.13 | +32.81% | 36 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 | $88.46 | +42.44% | 7 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $585 | $383.84 | n/a | 12 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $10 | $4.53 | n/a | 16 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $104.34 | n/a | 27 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $5 | $39.03 | n/a | 10 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $15.71 | n/a | 13 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $13 | $19.54 | n/a | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $24 | $20.50 | n/a | 6 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $575 | $395.18 | n/a | 22 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $20 | $40.83 | n/a | 18 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $55 | $89.05 | n/a | 20 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $31 | $48.06 | n/a | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $355 | $282.79 | n/a | 19 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $92 | $227.33 | n/a | 22 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $105 | $189.00 | n/a | 20 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $63 → $61 | $101.33 | n/a | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $300 | $391.68 | n/a | 16 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $375 | $229.74 | n/a | 20 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $142 | $145.69 | n/a | 18 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $32 | $21.55 | n/a | 16 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $565 | $427.89 | n/a | 21 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $86 | $65.73 | n/a | 11 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $1 → $2 | $33.15 | n/a | 8 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $35 → $34 | $38.46 | n/a | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $30 | $0.3656 | n/a | 6 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $16 | $1.52 | n/a | 10 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $5 | $0.8237 | n/a | 6 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $26 → $19 | $10.79 | n/a | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $15 | $8.66 | n/a | 3 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $6 → $10 | $3.28 | n/a | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 → $33 | $3.34 | n/a | 15 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $135 | $217.04 | n/a | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.86 | n/a | 1 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $19 → $14 | $5.10 | n/a | 3 | May 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $209.88 | n/a | 2 | Mar 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $49 | $215.75 | n/a | 1 | Sep 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $169.86 | n/a | 1 | Sep 17, 2013 |
Veeva Systems
Jun 3, 2026
Maintained: Buy
Price Target: $295 → $270
Current: $171.36
Upside: +57.56%
Doximity
May 14, 2026
Maintained: Hold
Price Target: $34 → $26
Current: $20.88
Upside: +24.52%
DENTSPLY SIRONA
May 6, 2026
Maintained: Hold
Price Target: $16 → $14
Current: $11.01
Upside: +27.16%
Henry Schein
May 6, 2026
Maintained: Hold
Price Target: $88 → $82
Current: $84.95
Upside: -3.47%
Align Technology
Apr 30, 2026
Maintained: Buy
Price Target: $215 → $220
Current: $178.43
Upside: +23.30%
Phreesia
Mar 24, 2026
Maintained: Buy
Price Target: $22 → $19
Current: $10.07
Upside: +88.68%
LifeMD
Mar 16, 2026
Upgraded: Buy
Price Target: $6 → $8
Current: $4.13
Upside: +93.70%
GoodRx Holdings
Feb 27, 2026
Maintained: Hold
Price Target: $4 → $3
Current: $2.80
Upside: +7.14%
Teladoc Health
Feb 26, 2026
Maintained: Hold
Price Target: $10 → $6
Current: $8.39
Upside: -28.49%
Medline
Feb 26, 2026
Maintained: Buy
Price Target: $48 → $53
Current: $38.87
Upside: +36.35%
Feb 20, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $5.22
Upside: +14.94%
Feb 10, 2026
Maintained: Buy
Price Target: $235
Current: $237.92
Upside: -1.23%
Feb 10, 2026
Maintained: Hold
Price Target: $885
Current: $763.51
Upside: +15.91%
Feb 10, 2026
Maintained: Hold
Price Target: $24 → $27
Current: $26.96
Upside: +0.15%
Feb 4, 2026
Maintained: Buy
Price Target: $50 → $42
Current: $19.90
Upside: +111.06%
Jan 20, 2026
Upgraded: Buy
Price Target: $85 → $100
Current: $79.53
Upside: +25.74%
Nov 6, 2025
Maintained: Buy
Price Target: $340 → $380
Current: $286.13
Upside: +32.81%
Jul 2, 2025
Reiterated: Buy
Price Target: $126
Current: $88.46
Upside: +42.44%
Aug 23, 2023
Rated: Buy
Price Target: $585
Current: $383.84
Upside: n/a
Aug 21, 2023
Rated: Buy
Price Target: $12 → $10
Current: $4.53
Upside: n/a
Aug 17, 2023
Rated: Buy
Price Target: $86
Current: $104.34
Upside: n/a
Aug 14, 2023
Rated: Sell
Price Target: $5
Current: $39.03
Upside: n/a
Aug 10, 2023
Maintained: Buy
Price Target: $7
Current: $15.71
Upside: n/a
Aug 10, 2023
Rated: Hold
Price Target: $13
Current: $19.54
Upside: n/a
Aug 10, 2023
Rated: Buy
Price Target: $25 → $24
Current: $20.50
Upside: n/a
Aug 8, 2023
Rated: Buy
Price Target: $575
Current: $395.18
Upside: n/a
Aug 8, 2023
Rated: Hold
Price Target: $20
Current: $40.83
Upside: n/a
Aug 7, 2023
Rated: Buy
Price Target: $55
Current: $89.05
Upside: n/a
Aug 4, 2023
Rated: Hold
Price Target: $31
Current: $48.06
Upside: n/a
Aug 3, 2023
Reiterated: Buy
Price Target: $355
Current: $282.79
Upside: n/a
Aug 1, 2023
Reiterated: Buy
Price Target: $82 → $92
Current: $227.33
Upside: n/a
Aug 1, 2023
Rated: Buy
Price Target: $105
Current: $189.00
Upside: n/a
Jul 28, 2023
Rated: Hold
Price Target: $63 → $61
Current: $101.33
Upside: n/a
Jul 27, 2023
Maintained: Hold
Price Target: $300
Current: $391.68
Upside: n/a
Jul 27, 2023
Rated: Buy
Price Target: $375
Current: $229.74
Upside: n/a
Jul 27, 2023
Rated: Hold
Price Target: $142
Current: $145.69
Upside: n/a
Jul 25, 2023
Maintained: Buy
Price Target: $33 → $32
Current: $21.55
Upside: n/a
Jul 14, 2023
Maintained: Buy
Price Target: $565
Current: $427.89
Upside: n/a
Jul 12, 2023
Maintained: Buy
Price Target: $100 → $86
Current: $65.73
Upside: n/a
Jun 29, 2023
Rated: Hold
Price Target: $1 → $2
Current: $33.15
Upside: n/a
May 3, 2023
Maintained: Sell
Price Target: $35 → $34
Current: $38.46
Upside: n/a
Mar 2, 2022
Maintained: Hold
Price Target: $45 → $30
Current: $0.3656
Upside: n/a
Mar 1, 2022
Maintained: Hold
Price Target: $22 → $16
Current: $1.52
Upside: n/a
Feb 8, 2022
Maintained: Hold
Price Target: $9 → $5
Current: $0.8237
Upside: n/a
Aug 12, 2021
Upgraded: Buy
Price Target: $26 → $19
Current: $10.79
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $19 → $15
Current: $8.66
Upside: n/a
Aug 3, 2021
Maintained: Sell
Price Target: $6 → $10
Current: $3.28
Upside: n/a
Feb 25, 2021
Maintained: Hold
Price Target: $23 → $33
Current: $3.34
Upside: n/a
Jan 15, 2021
Maintained: Buy
Price Target: $105 → $135
Current: $217.04
Upside: n/a
Jun 30, 2017
Downgraded: Sell
Price Target: n/a
Current: $9.86
Upside: n/a
May 15, 2017
Initiated Coverage: Hold
Price Target: $19 → $14
Current: $5.10
Upside: n/a
Mar 16, 2017
Upgraded: Hold
Price Target: n/a
Current: $209.88
Upside: n/a
Sep 17, 2013
Initiated Coverage: Hold
Price Target: $49
Current: $215.75
Upside: n/a
Sep 17, 2013
Initiated Coverage: Buy
Price Target: $50
Current: $169.86
Upside: n/a